中国组织工程研究 ›› 2017, Vol. 21 ›› Issue (23): 3694-3699.doi: 10.3969/j.issn.2095-4344.2017.23.015

• 脊柱植入物 spinal implant • 上一篇    下一篇

老年人脊柱手术后深静脉血栓的诊断与预防

杨利勇1,马海港2,李 振1,早东阳1,张 继1   

  1. 云南省大理市第一人民医院骨科,云南省大理市 671000;2内蒙古通辽市奈曼旗人民医院消化内镜室,内蒙古自治区通辽市 028300
  • 出版日期:2017-08-18 发布日期:2017-09-01
  • 作者简介:杨利勇,男,1968年生,云南省下关镇人,回族,1993年大理医学院(大理大学)毕业,副主任医生,主要从事骨科专业研究。

Diagnosis and prevention of deep vein thrombosis after spine surgery in the elderly  

Yang Li-yong1, Ma Hai-gang2, Li Zhen1, Zao Dong-yang1, Zhang Ji1   

  1. 1Department of Orthopedics, No. 1 People’s Hospital of Dali City, Dali 671000, Yunnan Province, China; 2Digestive Endoscopy Room, Naimanqi People’s Hospital, Tongliao 028300, Inner Mongolia Autonomous Region, China
  • Online:2017-08-18 Published:2017-09-01
  • About author:Yang Li-yong, Associate chief physician, Department of Orthopedics, No. 1 People’s Hospital of Dali City, Dali 671000, Yunnan Province, China

摘要:

文章快速阅读:

 
 

 

文题释义:
深静脉血栓:是指血液非正常地在深静脉内凝结,属于下肢静脉回流障碍性疾病。血栓形成大都发生于制动状态(尤其是骨科大手术)。致病因素有血流缓慢、静脉壁损伤和高凝状态三大因素。血栓形成后,除少数能自行消融或局限于发生部位外,大部分会扩散至整个肢体的深静脉主干,若不能及时诊断和处理,多数会演变为血栓形成后遗症,长时间影响患者的生活质量;还有一些患者可能并发肺栓塞,造成极为严重的后果。
纤维蛋白原:一种由肝脏合成的具有凝血功能的蛋白质。纤维蛋白是在凝血过程中,凝血酶切除血纤蛋白原中的血纤肽A和B而生成的单体蛋白质。简单地说,就是一种与凝血有关的蛋白质,即凝血因子。
 
摘要
背景:深静脉血栓是骨科术后常见并发症,预防和治疗下肢深静脉血栓至关重要,但是老年人脊柱手术后深静脉血栓发生率和预防研究的较少。
目的:探讨老年人脊柱手术后深静脉血栓的诊断及低分子肝素钙预防脊柱手术后深静脉血栓发生的疗效。
方法:将行脊柱手术的患者根据术后是否应用低分子肝素钙分为2组,未应用者为对照组,应用低分子肝素钙组在脊柱术后12 h皮下注射低分子肝素钙0.4 mL(4 100 IU),次日起每天1次皮下注射至7-14 d。治疗前及治疗结束后分别检测凝血活酶时间、凝血酶时间、活化部分凝血活酶时间、血浆纤维蛋白原;记录术后切口引流量及术前术后下肢血管彩超检查结果。
结果与结论:①低分子肝素钙组治疗后血浆纤维蛋白原降低, 凝血酶时间、凝血活酶时间、活化部分凝血活酶时间轻度延长,但均在正常范围内;②低分子肝素钙组深静脉血栓的发生为0,显著低于对照发生率5%(P < 0.05);③结果说明,脊柱手术后应用低分子肝素钙明显的降低了深静脉血栓发生。

中国组织工程研究杂志出版内容重点:人工关节;骨植入物;脊柱骨折;内固定;数字化骨科;组织工程
ORCID: 0000-0001-5874-692X(杨利勇)

关键词: 骨科植入物, 脊柱植入物, 深静脉血栓, 脊柱手术, 低分子肝素钙

Abstract:

BACKGROUND: Deep vein thrombosis is a common complication following bone surgeries, so its prevention and treatment become critical. However, there are few studies on the incidence of deep vein thrombosis after spine surgery in the elderly.

OBJECTIVE: To explore the diagnosis of deep vein thrombosis after spine surgery in the elderly and its incidence after intervention with low-molecular-weight heparin.
METHODS: All patients undergoing spine surgery were randomly divided into experimental and control groups. Patients in the experimental group were subjected to the subcutaneous injection of 0.4 mL of low-molecular-weight heparin (4 100 IU) at 12 hours postoperatively, once daily for 7-14 days from the next day. Those received no intervention served as controls. The thromboplastin time, thrombin time, activated partial thromboplastin time, and level of plasma fibrinogen were detected before and after treatment. Color Doppler ultrasound results of the lower extremity vessel before and after treatment and postoperative drainage volume were recorded.

RESULTS AND CONCLUSION: (1) In the experimental group, the lower level of plasma fibrinogen and slightly prolonged thromboplastin time, thrombin time and activated partial thromboplastin time were observed, but all were within the normal range. (2) The incidence of deep vein thrombosis in the experimental group (0%) was significantly lower than that in the control group (5%, P < 0.05). (3) To conclude, low-molecular-weight heparin therapy significantly reduced the incidence of deep vein thrombosis after spine surgery.

中国组织工程研究杂志出版内容重点:人工关节;骨植入物;脊柱骨折;内固定;数字化骨科;组织工程

Key words: Spine, Venous Thrombosis, Anticoagulants, Tissue Engineering

中图分类号: